Selective neutralization of APP-C99 with monoclonal antibodies reduces the production of Alzheimer's Aβ peptides.
about
A novel monoclonal antibody against the N-terminus of Aβ1-42 reduces plaques and improves cognition in a mouse model of Alzheimer's disease.Amyloid beta (Aβ) peptide modulators and other current treatment strategies for Alzheimer's disease (AD).Dynamic alteration of neprilysin and endothelin-converting enzyme in age-dependent APPswe/PS1dE9 mouse model of Alzheimer's disease.Zinc and Copper Differentially Modulate Amyloid Precursor Protein Processing by γ-Secretase and Amyloid-β Peptide Production.
P2860
Selective neutralization of APP-C99 with monoclonal antibodies reduces the production of Alzheimer's Aβ peptides.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Selective neutralization of AP ...... on of Alzheimer's Aβ peptides.
@en
Selective neutralization of AP ...... on of Alzheimer's Aβ peptides.
@nl
type
label
Selective neutralization of AP ...... on of Alzheimer's Aβ peptides.
@en
Selective neutralization of AP ...... on of Alzheimer's Aβ peptides.
@nl
prefLabel
Selective neutralization of AP ...... on of Alzheimer's Aβ peptides.
@en
Selective neutralization of AP ...... on of Alzheimer's Aβ peptides.
@nl
P2093
P1476
Selective neutralization of AP ...... on of Alzheimer's Aβ peptides.
@en
P2093
Jemila Houacine
Lorène Aeschbach
Mustapha Oulad-Abdelghani
Tristan Bolmont
P304
P356
10.1016/J.NEUROBIOLAGING.2011.12.033
P577
2012-02-07T00:00:00Z